JAN Janus Living
Janus Living earnings company data as of 4:46 AM ET 10/24
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 2 Nov | EPS | 0.24 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by JAN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $3.7M bought by 6 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Katherine M Sandstrom DirectorBuy$270K 13,500 shares at $20.00 +180% to stakeTraded Mar 23 Filed Mar 24
-
Denise Olsen DirectorBuy$10K 500 shares at $20.00 +6.7% to stakeTraded Mar 23 Filed Mar 24
-
Charles J Herman Jr. DirectorBuy$110K 5,500 shares at $20.00 +73% to stakeTraded Mar 23 Filed Mar 24
-
John V Arabia DirectorBuy$1.2M 60,000 shares at $20.00 +800% to stakeTraded Mar 23 Filed Mar 24
-
Scott M Brinker CEOBuy$2M 100,000 shares at $20.00 New stakeTraded Mar 23 Filed Mar 24
-
Jeffrey H Miller COOBuy$150K 7,500 shares at $20.00 New stakeTraded Mar 23 Filed Mar 24
Also filed in the last 12 months, not counted as buying or selling: 8 stock grants.
SEC filings
Recent issuer filings from EDGAR, 12 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 1.01,2.03,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B4 | Filing Doc | ||
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B4 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 424B4 | Filing Doc | ||
| 8-K | 1.01,2.03,5.02,5.03,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.